INS and type 2 diabetes mellitus: Similarly, a positive association has been observed between C-peptide and colorectal cancer risk in nested case-control studies, especially in men [15], and Mendelian randomization studies have supported causal association between higher-fasting insulin (but not glucose traits or type 2 diabetes) and colorectal cancer risk [16].